This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bajoria, R. Articles by Babawale, M. Search for Related Content PubMed PubMed Citation Articles by Bajoria, R. Articles by Babawale, M.

Ontogeny of Endogenous Secretion of Immunoreactive-Thyrotropin Releasing Hormone by the Human Placenta

Imperial College of Science, Technology and Medicine, Division of Paediatrics, Obstetrics and Gynaecology, Institute of Obstetrics & Gynaecology, Hammersmith Hospital, Du Cane Road, London, United Kingdom

Address correspondence and requests for reprints to: Dr. Rekha Bajoria, Department of Obstetrics & Gynaecology, Research Floor, St. Mary’s Hospital, Whitworth Park, Manchester M13 0JH, United Kingdom. E-mail: rekha.bajoria{at}man.ac.uk

We studied endogenous production of immunologically active TRH (ir-TRH) by human placenta throughout gestation. Fragments (20 g) of placentae obtained between 7 and 41 weeks’ gestation were incubated in TC-199 media with or without TRH degrading enzyme inhibitors (1 mM of dithiothreitol, 200 µm O-phenanthroline, 0.8 mM EDTA) at 37 C for 24 h. TRH was quantitated by RIA. Release of ir-TRH was also studied in an in vitro model of dually-perfused isolated lobule of human term placenta. Cellular localization of TRH was performed by staining early-, mid- and late-gestation placentae with anti-TRH rabbit polyclonal antibody, using the indirect avidin-biotin complex immunoperoxidase method.

TRH was produced by placental fragments from 7 to 41 weeks’ gestation. Placental TRH secretion was maximal between 7–12 weeks gestation both in presence (655 ± 79 pg/10 mg protein) and absence (423 ± 75 pg/10 mg protein) of enzyme inhibitors. Secretion of TRH declined with increasing gestation both with (y = 779 - 15x; r = 0.90; P < 0.001; n = 15) and without (y = 525 - 12x; r = 0.87; P < 0.001; n = 15) enzyme inhibitors. In the perfusion experiments, endogenous TRH was released predominantly into the fetal circulation, and its concentration was markedly higher in the presence of enzyme inhibitors (146 ± 27 vs. 34 ± 7 pg/mL; P < 0.001). Immunostaining of chorionic villi localized TRH to the cytoplasm of the syncytial layer, and the intensity declined with advancing gestational age. These data suggest that immunoactive TRH is produced by human placenta begin at 7 weeks gestation, and production declines with gestational age.

This article has been cited by other articles:

				C. Ferretti, L. Bruni, V. Dangles-Marie, A.P. Pecking, and D. Bellet Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts Hum. Reprod. Update, March 1, 2007; 13(2): 121 - 141. [Abstract] [Full Text] [PDF]